Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software

AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests

Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories

Twist Bioscience Earns 2021 Great Place to Work Certification™

Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery

Twist Bioscience and Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay

Twist Bioscience Functional GLP-1R Antibodies Identified From Its Proprietary Synthetic DNA GPCR Libraries Demonstrate Potent Blood Glucose Control

Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing